To the procedure of confirmation of the laboratory’s competence in performing mutagenicity assessment using the Ames test
- Authors: Egorova O.V.1
-
Affiliations:
- FBES “Federal Scientific Center of Hygiene named after F.F. Erisman” of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
- Issue: No 4 (2021)
- Pages: 4-13
- Section: Reviews
- Published: 03.09.2021
- URL: https://consilium.orscience.ru/0869-7922/article/view/641320
- DOI: https://doi.org/10.36946/0869-7922-2021-29-4-4-13
- ID: 641320
Cite item
Full Text
Abstract
Introduction. The bacterial reverse mutation test (Ames test, OECD* guideline No. 471) is one of the most popular methods for assessing mutagenicity due to its ease of use and the ability to detect up to 70–80% of substances with carcinogenic activity. The experimental protocol requires a minimum amount of test item and standard microbiological laboratory equipment. To obtain the raw data, several days from the start of the experiment are required.
Despite the existence of publications devoted to the detailed description of the standard Ames test protocol, there is a gap in a number of aspects of the procedure for confirming the competence of a test facility using this method in its practice.
Materials and methods. When preparing this article, we used the literature data published in Russian and foreign literature over the past 20 years concerning experimental approaches to the implementation of the Ames test. The literature search was carried out in the Scopus, Medline, Google Scholar, RSCI databases.
Results. In the FBES “Federal Scientific Center of Hygiene named after F.F. Erisman” of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing the bacterial mutation assay has found application in studying the safety of technical grade active ingredients of pesticides, their mixtures and formulation, as well as in the assessment of equivalence. The test facility on the basis of the FBES “Federal Scientific Center of Hygiene named after F.F. Erisman” of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing is accredited for compliance with the state standard GOST ISO / IEC 17025-2019” General requirements for the competence of testing and calibration laboratories. “In this article, based on new published data and our own practical experience, a number of necessary conditions are considered for demonstrating the competence of a testing laboratory using the Ames test in its practice, its ability to obtain reliable results and take actions to manage the risks of laboratory activities. The main attention is paid to ensuring such parameters of the test quality as indicator cultures, metabolic activation system, control of the background of spontaneous mutation, etc.
Conclusion. The discussed practical issues can be useful for specialists from research laboratories planning to introduce this method into practice.
About the authors
Olga V. Egorova
FBES “Federal Scientific Center of Hygiene named after F.F. Erisman” of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
Author for correspondence.
Email: egorovaov@fferisman.ru
ORCID iD: 0000-0003-4748-8771
Senior researcher of the department of genetic toxicology, FBES “F.F. Erisman Federal Scientific Center of Hygiene” of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, 141014, Mytishchi, Russia.
e-mail: egorovaov@fferisman.ru
Russian FederationReferences
- Abilev S., Glazer V. Mutagenesis with the basic principles of genotoxicology: a tutorial [Mutagenez s osnovami genotoksikologii: uchebnoe posobie]. Moscow-SPb.: Nestor-Istoriya; 2015 (In Russian)
- Zeiger E. The test that changed the world: The Ames test and the regulation of chemicals. Mut Research/Genetic Toxicol Environ Mutagenesis. 2019; 841: 43-8.
- OECD Test No. 471: Bacterial reverse mutation test. OECD Guidelines for the Testing of Chemicals, Section 4. 2020. Publishing, Paris. https://doi.org/10.1787/9789264071247-en
- Rakitskiy V., Revazova Yu., Ilyushina N. Strategy and tactics of the pesticide mutagenicity assessment. Toksikologicheskiy vestnik. 2015; 134(5): 10-3. (In Russian)
- Egorova O., Ilyushina N., Rakitskii V. Mutagenicity evaluation of pesticide analogs using standard and 6-well miniaturized bacterial reverse mutation tests. Toxicology in Vitro. 2020; 69:105006
- Egorova O., Ilyushina N., Averianova N., Masaltsev G., Dmitricheva O. Assessment of the mutagenicity of the technical product of N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine. Gigiena i sanitariya. 2020; 99(4): 418-24. (In Russian)
- Maron D., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mut Research/Environ Mutagenesis and Related Subjects. 1983; 113 (3-4): 173-215.
- Fonshtejn L.M., Kalinina L.M., Poluhina G.N. i Abilev S.K., Shapiro A.L. Test system for the assessment of environmental pollutants in S. typhimurium. Moscow: VINITI$ 1997, 52 .
- Zeiger E. Bacterial Mutation Assays. Genotoxicity Assessment. Methods in Molecular Biology (Methods and Protocols). 2013; 1044: 3-26.
- Krasovskij G.N., ZHurkov V.S., Zholdakova Z.I., Fonshtejn L.M., Abilev S.A., Bobrinev E.V. et al. Methodological instructive regulations on the study of mutagenicity of chemicals under justification of MAC in water. Moscow: Ministry of Health of the USSR; Main Sanitary and Epidemiological Department [Metodicheskie ukazaniya po izucheniyu mutagennoj aktivnosti khimicheskikh veshchestv pri obosnovanii ikh PDK v vode]. Moscow: Minzdrav SSSR; Glavnoe sanitarno-ehpidemiologicheskoe upravlenie. .. 1986. (In Russian)
- Hamel A., Roy M., Proudlock R. The bacterial reverse mutation test. Chapter 4. In Proudlock R. Еd. Genetic Toxicology Testing. A Laboratory Manual. 2016: 79-138.
- Mortelmans K., Zeiger E. The Ames Salmonella/microsome mutagenicity assay. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 2000; 455 (1-2): 29-60.
- Levy D.D, Hakura A, Elespuru R.K, Escobar P.A, Kato M, Lott J. et al. Demonstrating laboratory proficiency in bacterial mutagenicity assays for regulatory submission. Mut Research/Genetic Toxicol Environ Mutagenesis. 2018; 848:403075.
- Bock KW, Lipp HP, Bock-Hennig BS. Induction of drug-metabolizing enzymes by xenobiotics. Xenobiotica. 1990; 20(11):1101-11.
- Mori Y., Koide A., Fuwa K., Kobayashi Y. N. Benzylimidazole for preparation of S9 fraction with multi-induction of metabolizing enzymes in short-term genotoxicity assays. Mutagenesis. 2001; 16(6): 479-86.
- Burke D, Wedd D, Herriott D, Bayliss M, Spalding D, Wilcox P. Evaluation of pyrazole and ethanol induced S9 fraction in bacterial mutagenicity testing. Mutagenesis. 1994; 9(1):23-9.
- Maron D, Katzenellenbogen J., Ames B.N. Compatibility of organic solvents with the Salmonella/microsome test. Mutation Research/Genetic Toxicology. 1981; 88 (4): 343-50.
- Levy D.D., Zeiger E., Escobar P.A., Hakura A, van der Leede M. B.-J, Kato M et. al. Recommended criteria for the evaluation of bacterial mutagenicity data (Ames test). Mut Research/Genetic Toxicol Environ Mutagenesis. 2019; 848: 403074.
- Egorova O.V., Demidova Yu.V., Ilyushina N.A. Assessment of experimental conditions affecting spontaneous mutation level of Salmonella strains used in the Ames test. Gigiena i Sanitariya. 2021;100 (7):736-43 (In Russian).
- ICH Harmonised Tripartite Guideline S2(R1). Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. 2012. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/s2r1-genotoxicity-testing-and-data-interpretation-pharmaceuticals-intended-human-use
Supplementary files
